Schedule 13G ownership disclosure

ANIKA THERAPEUTICS INC

Security class unavailable · CUSIP: 035255108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
915,596
Percent of class
6.4100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-018686
Form type
SC 13G/A
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub